The COVID-19 pandemic evidenced the urgent need for rapid, accurate, and scalable diagnostic methods for emerging infectious diseases. Droplet digital reverse transcription loop-mediated isothermal amplification (ddRT-LAMP) is a promising technique for pathogen detection and DNA or RNA quantification. Compared to ddPCR, it simplifies device design, reduces power consumption and analysis time, and enhances compatibility with miniaturization, making it ideal for portable, high-throughput nucleic acid detection applications. However, many parameters must be adjusted according to the application to avoid spurious results. This study critically examines key conditions for an effective ddRT-LAMP assay to quantify copies of SARS-CoV-2 N gene coded in plasmid DNA, synthetic viral RNA, or patients’ nasopharyngeal swab samples. Using a polydimethylsiloxane (PDMS) microfluidic device, the RT-LAMP reaction mixture with a fluorescent dye was divided into thousands of droplets stabilized by a surfactant in fluorinated oil. After incubation, the droplets were injected into a PDMS chamber for fluorescent imaging to determine the proportion of positive droplets and quantify the samples based on Poisson distribution. Samples with viral loads up to 102 copies/µL were quantified with high precision. Results showed that primer design and master mix composition significantly impacted the amplification. Selection of GelGreen® as the fluorescent dye was crucial, as other dyes tested diffused into the oil phase. Droplets with a diameter of around 105 µm and an incubation time of 30 min were required to achieve maximum amplification. By addressing these operational challenges, ddRT-LAMP can become a more effective tool for viral detection and quantification in clinical diagnostics.